Positive topline results from phase 2 recurrent ovarian cancer trial
Rare oral cancer has distinct genetic profile
New tool decodes structures and motifs of RNA
Elite immune cells lead fight against multiple myeloma
Base to Base biotech podcast 43: Natural killer cell therapy and attacking tumours
Brainomix e-Lung AI imaging technology selected in Boehringer Ingelheim pulmonary fibrosis trial
Scientists uncover hidden cells fuelling brain cancer — and a drug that could stop them
Wiskott-Aldrich syndrome treatment approved
Positive phase 3 results from insomnia trial
AbbVie announces topline results for phase 3 lymphoma trial
Novo Nordisk Foundation grants $860m to boost innovation in Denmark and Europe
University of Pennsylvania, BioNTech, and OUP launch $50m life sciences fund